Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technologies to basic science cancer researchers – to create an environment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imaging adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

Dr. Levin Receives AAPM Sylvia & Moses Greenfield Paper Award

May 23, 2018

Andrew Groll, PhD, Selected as Ford Foundation 2018 Postdoctoral Fellowship Competition Awardee

May 21, 2018

PET Scan Tracer Predicts Success of Cancer ‘Vaccine’

May 14, 2018

MIPS Research Featured on the Cover of Oncotarget

April 20, 2018

Drs. Daldrup-Link and Rao Elected to AIMBE College of Fellows

April 9, 2018

MIPS Research Featured as the Inside Front Cover in the Chemical Science

March 25, 2018

Dr. Raag Airan Received ASCI's 2018 Young Physician-Scientist Award

March 19, 2018